secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2026-09-02T12:35:05+00:00
Accession:  0001193125-26-379423
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Allogene CFO Geoffrey Parker to retire effective Nov 6, 2026
------------------------------------------------------------

- Geoffrey Parker, EVP and CFO, notified company of retirement on Aug 31, 2026.
- Retirement effective November 6, 2026; he will depart in all capacities.
- No successor named in the filing; company has not announced a replacement.
- Parker served as principal financial officer; transition period of ~2 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/0001193125-26-379423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/d522964d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-379423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer